TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Bioresorbable Implants market was valued at 5177.39 Million USD in 2021 and will grow with a CAGR of 4.7% from 2021 to 2027, based on Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Conventional implants were used by orthopedic surgeons previously to fix internal fixation for years. These implants have required a lot of development over the decades. Regardless it`s wide spread use, there are some problems associated with conventional implants which include the potential for long term relocation, stress shielding, breakage, reaction of the material, interference with the imaging devices and restricted growth in young patients. Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by the natural bones. The implants which are somewhat large, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. By the additive manufacturing technology, this interconnecting porous structure can be manufactured directly.There are many factors which are driving the bioresorbable implants market like increasing incidences of chronic diseases, rising geriatric population, increasing incidences of road accidents growing disposable incomes and high level of healthcare. Additionally, the applications are increasing in medical and dental streams which are boosting the bioresorbable implants market.One of the most restraining factors of bioresorbable polymers is their inherent low strength compared to metals. Major tissue reactions have been reported in some cases. However, the time consuming approval processes of bioresorbable implants by the regulatory authorities, the reimbursement and the high cost of treatment will affect the bioresorbable implants market negatively.
By Market Vendors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase